@article {Malosh2020.03.24.20042556, author = {Ryan E. Malosh and Joshua G. Petrie and Amy P. Callear and Arnold S. Monto and Emily T. Martin}, title = {Home collection of nasal swabs for detection of influenza in the Household Influenza Vaccine Evaluation Study}, elocation-id = {2020.03.24.20042556}, year = {2020}, doi = {10.1101/2020.03.24.20042556}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Community based studies of influenza and other respiratory viruses (e.g. SARS-COV-2) require laboratory confirmation of infection. During the current COVID-19 pandemic, social distancing guidelines require alternative data collection in order protect both research staff and participants.Home-collected respiratory specimens are less resource intensive, can be collected earlier after symptom onset, and provide a low-contact means of data collection. A prospective, multi-year, community-based cohort study is an ideal setting to examine the utility of home-collected specimens for identification of influenza.Methods We describe the feasibility and reliability of home-collected specimens for the detection of influenza. We collected data and specimens between October 2014 and June 2017 from the Household Influenza Vaccine Evaluation (HIVE) Study. Cohort participants were asked to collect a nasal swab at home upon onset of acute respiratory illness. Research staff also collected nose and throat swab specimens in the study clinic within 7 days of onset. We estimated agreement using Cohen{\textquoteright}s kappa and calculated sensitivity and specificity of home-collected compared to staff-collected specimens.Results We tested 336 paired staff- and home-collected respiratory specimens for influenza by RT-PCR; 150 staff-collected specimens were positive for influenza A/H3N2, 23 for influenza A/H1N1, 14 for influenza B/Victoria, and 31 for influenza B/Yamagata. We found moderate agreement between collection methods for influenza A/H3N2 (0.70) and B/Yamagata (0.69) and high agreement for influenza A/H1N1 (0.87) and B/Victoria (0.86). Sensitivity ranged from 78-86\% for all influenza types and subtypes. Specificity was high for influenza A/H1N1 and both influenza B lineages with a range from 96-100\%, and slightly lower for A/H3N2 infections (88\%).Conclusions Collection of nasal swab specimens at home is both feasible and reliable for identification of influenza virus infections.Competing Interest StatementREM, JGP, and APC have no conflicts of interest to disclose. ASM reports personal fees from Sanofi Pasteur and Sequirus outside the current work. ETM reports grants from Pfizer and personal fees from Merck outside the current work.Funding StatementThe HIVE study is supported by the Centers for Disease Control and Prevention (U01 IP000474) and the National Institute for Allergy and Infectious Diseases (R01 AI097150).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, REM, upon reasonable request.}, URL = {https://www.medrxiv.org/content/early/2020/03/26/2020.03.24.20042556}, eprint = {https://www.medrxiv.org/content/early/2020/03/26/2020.03.24.20042556.full.pdf}, journal = {medRxiv} }